
Loading, please wait...

Loading, please wait...

Lower extremity artery disease (LEAD) presents significant diagnostic challenges due to overlapping pathology. Medial Artery Calcification (MAC) is a hallmark of this condition, yet current imaging often fails to distinguish it from intimal artery calcification (IAC). A comprehensive study recently analyzed 3,566 cross-sections to map these calcification patterns. Consequently, clinicians can now better understand the spatial relationship between these two distinct arterial processes.
Researchers discovered that MAC and IAC exhibit a striking inverse distribution. While MAC is significantly more extensive in below-the-knee (BTK) arteries, IAC is more prevalent in the above-the-knee (ATK) segments. Specifically, analysis revealed MAC in over 91% of arterial segments, highlighting its nearly universal presence in advanced LEAD. Furthermore, medial bone formation occurred in 16% of segments, representing a severe, advanced stage of the disease. Notably, patients with chronic kidney disease (CKD) showed a much higher burden of MAC compared to others.
Understanding these pathological insights is vital for tailoring vascular interventions. For example, high MAC burden often correlates with increased arterial stiffness, which can complicate endovascular procedures. However, the study confirms that MAC and IAC generally develop in different arterial regions. Therefore, clinicians must consider these distinct patterns when planning revascularization strategies for their patients.
MAC increases arterial stiffness and reduces vessel compliance. Consequently, this can make balloon angioplasty or stenting more difficult, often requiring specialized techniques like intravascular lithotripsy to achieve adequate vessel expansion.
These two types of calcification have different clinical associations and locations. IAC primarily links to atherosclerotic plaque and dominates larger proximal arteries. In contrast, MAC is more common in distal segments and is strongly associated with metabolic factors like diabetes and chronic kidney disease.
Medial bone formation represents the most advanced stage of MAC. It is associated with a massive calcification burden and significantly alters the structural integrity of the arterial wall. This finding may predict poorer outcomes after standard endovascular interventions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A comprehensive pathological study reveals that medial and intimal calcification follow distinct, inverse distribution patterns in the lower extremities, with medial calcification significantly linked to chronic kidney disease.
4 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today